Banner - NPPA Connect
Opinion|Videos|January 17, 2025

Practice Pearls for Managing Patients With Prurigo Nodularis

A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.

Video content above is prompted by the following:

  • Based on our discussion today, what key insights or new perspectives could you share regarding treatment considerations for systemic therapies for prurigo nodularis?
  • What take-home messages or practice pearls do you have for clinicians treating patients with prurigo nodularis?